Cytogenetic Studies in Acute Promyelocytic Leukemia: A Survey of Secondary Chromosomal Abnormalities
✍ Scribed by Dr. Roland Berger; Maryvonne Le Coniat; Josette Derré; Danièle Vecchione; Philippe Jonveaux
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 455 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A series of 105 patients with acute promyelocytic leukemia (APL) has been cytogenetically investigated at the Department of Hematology of the Saint‐Louis Hospital (Paris) between 1977 and 1990. Sixty‐two patients were examined at diagnosis, 32 in relapse, and 11 both at diagnosis and in relapse. The typical t( 15; 17)(q22;q 12) or variants of this translocation were observed in all but four patients. The t(15;17) was the only change in 47 cases at diagnosis and in 21 examined in relapse. The most frequent secondary change was trisomy 8 (17% at diagnosis). More or less complex chromosomal abnormalities in addition to t(15;17) were present in six patients at diagnosis, and in 17 patients in relapse. Rearrangements of 2q35‐q37 and del(11p) were observed only in relapse and may thus be nonrandom secondary changes. Cytogenetic studies performed on 19 patients treated with all‐trans retinoic acid did not indicate that this treatment induces chromosomal abnormalities.
📜 SIMILAR VOLUMES
## Abstract We have previously reported on two patients with acute promyelocytic leukemia (APL) who had what appeared to be a deletion of chromosome No. 17. We now describe a third patient with APL. All three patients had a structural rearrangement involving No. 15 and No. 17. Our current interpret
Acute promyelocytic leukemia (APL) is usually associated with the translocation t( 15; I7)(q22;q 12-2 I), which disrupts the retinoic acid receptor alpha (RAM) gene on chromosome I7 and the PML gene on chromosome 15. We report a patient with typical APL without the common t( 15; 17). Cytogenetic stu
## Background: The authors have determined the prognostic significance of cytogenetically detectable 12p abnormalities, which are frequent in children with acute lymphoblastic leukemia (all), in a large cohort of patients treated on risk-adjusted protocols of the children's cancer group (ccg). ##